EUR 51,89
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : NEW.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 58,51
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
EUR 57,72
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierPaperback / softback. Etat : New. New copy - Usually dispatched within 4 working days. 598.
Vendeur : Chiron Media, Wallingford, Royaume-Uni
EUR 55,25
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierpaperback. Etat : New.
EUR 60,02
Autre deviseQuantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Vendeur : California Books, Miami, FL, Etats-Unis
EUR 64,79
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
EUR 63,54
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. Scott M. Berry is the President and Senior Statistical Scientist at Berry Consultants, a statistical consulting group specializing in adaptive clinical trial design in pharmaceutical and medical device research and development.
EUR 58,03
Autre deviseQuantité disponible : 10 disponible(s)
Ajouter au panierEtat : New.
EUR 67,71
Autre deviseQuantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 52,48
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
EUR 67,83
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. 324 pages. 9.18x6.12x9.21 inches. In Stock.
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 70,05
Autre deviseQuantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 65,92
Autre deviseQuantité disponible : 9 disponible(s)
Ajouter au panierEtat : New.
EUR 66,31
Autre deviseQuantité disponible : 10 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 73,19
Autre deviseQuantité disponible : 9 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
EUR 84,87
Autre deviseQuantité disponible : 2 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. 324 pages. 9.18x6.12x9.21 inches. In Stock.
Edité par Taylor & Francis Ltd, London, 2024
ISBN 10 : 1032922052 ISBN 13 : 9781032922058
Langue: anglais
Vendeur : CitiRetail, Stevenage, Royaume-Uni
EUR 72,04
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. Paperback. Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions, from Alzheimers disease and multiple sclerosis to obesity, diabetes, hepatitis C, and HIV. Written by leading pioneers of Bayesian clinical trial designs, Bayesian Adaptive Methods for Clinical Trials explores the growing role of Bayesian thinking in the rapidly changing world of clinical trial analysis.The book first summarizes the current state of clinical trial design and analysis and introduces the main ideas and potential benefits of a Bayesian alternative. It then gives an overview of basic Bayesian methodological and computational tools needed for Bayesian clinical trials. With a focus on Bayesian designs that achieve good power and Type I error, the next chapters present Bayesian tools useful in early (Phase I) and middle (Phase II) clinical trials as well as two recent Bayesian adaptive Phase II studies: the BATTLE and ISPY-2 trials. In the following chapter on late (Phase III) studies, the authors emphasize modern adaptive methods and seamless Phase IIIII trials for maximizing information usage and minimizing trial duration. They also describe a case study of a recently approved medical device to treat atrial fibrillation. The concluding chapter covers key special topics, such as the proper use of historical data, equivalence studies, and subgroup analysis.For readers involved in clinical trials research, this book significantly updates and expands their statistical toolkits. The authors provide many detailed examples drawing on real data sets. The R and WinBUGS codes used throughout are available on supporting websites.Scott Berry talks about the book on the CRC Press YouTube Channel. Written by leading pioneers of Bayesian clinical trial designs, this book explores the growing role of Bayesian thinking in clinical trial analysis. Covering Phase I, II, and III clinical trials, it establishes the basic principles before extending them to specific phases and endpoints. The authors also discuss special topics that span different Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Edité par Taylor & Francis Ltd, London, 2024
ISBN 10 : 1032922052 ISBN 13 : 9781032922058
Langue: anglais
Vendeur : AussieBookSeller, Truganina, VIC, Australie
EUR 76,64
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. Paperback. Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions, from Alzheimers disease and multiple sclerosis to obesity, diabetes, hepatitis C, and HIV. Written by leading pioneers of Bayesian clinical trial designs, Bayesian Adaptive Methods for Clinical Trials explores the growing role of Bayesian thinking in the rapidly changing world of clinical trial analysis.The book first summarizes the current state of clinical trial design and analysis and introduces the main ideas and potential benefits of a Bayesian alternative. It then gives an overview of basic Bayesian methodological and computational tools needed for Bayesian clinical trials. With a focus on Bayesian designs that achieve good power and Type I error, the next chapters present Bayesian tools useful in early (Phase I) and middle (Phase II) clinical trials as well as two recent Bayesian adaptive Phase II studies: the BATTLE and ISPY-2 trials. In the following chapter on late (Phase III) studies, the authors emphasize modern adaptive methods and seamless Phase IIIII trials for maximizing information usage and minimizing trial duration. They also describe a case study of a recently approved medical device to treat atrial fibrillation. The concluding chapter covers key special topics, such as the proper use of historical data, equivalence studies, and subgroup analysis.For readers involved in clinical trials research, this book significantly updates and expands their statistical toolkits. The authors provide many detailed examples drawing on real data sets. The R and WinBUGS codes used throughout are available on supporting websites.Scott Berry talks about the book on the CRC Press YouTube Channel. Written by leading pioneers of Bayesian clinical trial designs, this book explores the growing role of Bayesian thinking in clinical trial analysis. Covering Phase I, II, and III clinical trials, it establishes the basic principles before extending them to specific phases and endpoints. The authors also discuss special topics that span different Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Vendeur : Chiron Media, Wallingford, Royaume-Uni
EUR 107,91
Autre deviseQuantité disponible : 5 disponible(s)
Ajouter au panierHardcover. Etat : New.
Edité par Taylor & Francis Ltd, London, 2024
ISBN 10 : 1032922052 ISBN 13 : 9781032922058
Langue: anglais
Vendeur : Grand Eagle Retail, Mason, OH, Etats-Unis
EUR 69,86
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. Paperback. Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions, from Alzheimers disease and multiple sclerosis to obesity, diabetes, hepatitis C, and HIV. Written by leading pioneers of Bayesian clinical trial designs, Bayesian Adaptive Methods for Clinical Trials explores the growing role of Bayesian thinking in the rapidly changing world of clinical trial analysis.The book first summarizes the current state of clinical trial design and analysis and introduces the main ideas and potential benefits of a Bayesian alternative. It then gives an overview of basic Bayesian methodological and computational tools needed for Bayesian clinical trials. With a focus on Bayesian designs that achieve good power and Type I error, the next chapters present Bayesian tools useful in early (Phase I) and middle (Phase II) clinical trials as well as two recent Bayesian adaptive Phase II studies: the BATTLE and ISPY-2 trials. In the following chapter on late (Phase III) studies, the authors emphasize modern adaptive methods and seamless Phase IIIII trials for maximizing information usage and minimizing trial duration. They also describe a case study of a recently approved medical device to treat atrial fibrillation. The concluding chapter covers key special topics, such as the proper use of historical data, equivalence studies, and subgroup analysis.For readers involved in clinical trials research, this book significantly updates and expands their statistical toolkits. The authors provide many detailed examples drawing on real data sets. The R and WinBUGS codes used throughout are available on supporting websites.Scott Berry talks about the book on the CRC Press YouTube Channel. Written by leading pioneers of Bayesian clinical trial designs, this book explores the growing role of Bayesian thinking in clinical trial analysis. Covering Phase I, II, and III clinical trials, it establishes the basic principles before extending them to specific phases and endpoints. The authors also discuss special topics that span different Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
EUR 133,80
Autre deviseQuantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. 323.
Vendeur : Treasure Island, Waltham, MA, Etats-Unis
EUR 82,30
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierhardcover. Etat : New.
Vendeur : Best Price, Torrance, CA, Etats-Unis
EUR 121,83
Autre deviseQuantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. SUPER FAST SHIPPING.
EUR 135,58
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : California Books, Miami, FL, Etats-Unis
EUR 146,22
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 151,12
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 146,84
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
EUR 159,13
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 165,44
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
EUR 129,54
Autre deviseQuantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.